Efficacy of a Mobile Phone App for Depression and Anxiety in College Students
Launched by UNIVERSITY OF CHILE · Oct 3, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PHQ-9 and GAD-7 score between 5 and 14 points
- • Have a stable internet connection
- • To provide informed consent
- Exclusion Criteria:
- • High risk of suicide according to C-SSRS
- • Currently undergoing psychological, psychiatric and/or psychopharmacological treatment
- • Bipolar disorder, psychotic disorder or substance use disorder assessed with the respective modules of the MINI interview.
About University Of Chile
The University of Chile, a leading academic institution in South America, is dedicated to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on collaboration among multidisciplinary teams, the university leverages its extensive resources and expertise to conduct rigorous and ethically sound studies. By integrating cutting-edge scientific methodologies and fostering partnerships with healthcare providers, the University of Chile aims to contribute valuable insights to the medical community and enhance patient care both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santiago, Region Metropolitana, Chile
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported